Sharda Cropchem Limited Earnings Summary — Q1 FY2027
Sharda Cropchem Reports Growth in Q1 FY2027 as Revenue Climbs 9% to ₹1,074 Crore
Key Takeaways
- Consolidated revenue from operations grew 9.03% year-on-year to ₹1,073.8 crore, led primarily by the Agrochemicals segment.
- The Agrochemicals segment revenue rose to ₹914.9 crore, up from ₹846.2 crore in the same period last year, despite global seasonality.
- Profitability faced pressure with Net Profit declining 38.4% YoY to ₹88.0 crore, largely due to higher purchase costs and finance expenses.
- Non-agrochemicals segment (Belts, Dyes, and General Chemicals) showed resilient performance with revenue growing to ₹158.9 crore.
- Operating expenses spiked, specifically 'Purchase of stock in trade', which increased to ₹476.4 crore from ₹315.3 crore YoY.
- Foreign exchange gains of ₹7.5 crore provided a partial hedge, though this was significantly lower than the ₹73.1 crore gain in Q1 FY26.
- The company maintains an asset-light model with significant investments in global registrations, reflected in ₹100.3 crore depreciation and amortization.
Management Guidance
Management noted that the Agrochemicals segment is inherently seasonal and performance is heavily dependent on global cropping patterns and weather conditions. Consequently, Q1 results should not be viewed as representative of the full year's expected performance.
Sentiment Shift
Stable
While revenue showed steady growth, the sharp decline in net profit and compressed margins reflect rising cost pressures that offset volume gains.
Outlook
The outlook remains focused on navigating global agrochemical cycles and leveraging their vast portfolio of registrations. Continued volatility in raw material pricing and logistics remains a key monitorable.
From the Annual Report (Key Quotes)
“One of the major segments of the Group, viz 'Agrochemicals', is seasonal in nature and its performance can be impacted by cropping pattern and weather conditions across the globe.”
“Quarterly figures are not representative of the other quarters and full year's performance.”
“The aforesaid financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on July 29, 2026.”
Official Quarterly Documents
Ask AI about this quarter
This summary is AI-generated from Sharda Cropchem Limited's latest quarterly filing and earnings call. For informational purposes only — not investment advice.